by Jordana Choucair | Dec 23, 2021 | Life Sciences
Novavax and AstraZeneca announced that its COVID-19 vaccine is effective in generating an immune response against the Omicron variant. Yesterday, Novavax said early data from its booster and adolescent studies showed “broad cross-reactivity” against Omicron and other...
by Jordana Choucair | Dec 23, 2021 | Life Sciences
The FDA authorized Pfizer Inc.’s Paxlovid for high-risk patients 12 and older, making it the first antiviral pill to treat COVID-19 in the United States. Even so, it will likely be months before the pills are widely available. Jeff Zients, coordinator of the...
by Jordana Choucair | Dec 21, 2021 | Life Sciences
Biogen said that it has reduced the price of its Alzheimer’s drug Aduhelm by half. The moves follow a disappointing commercial launch of Aduhelm, as well as anger over the drug’s high price. Biogen also said it is planning a series of cost-cutting measures across the...
by Jordana Choucair | Dec 20, 2021 | Life Sciences
Moderna said preliminary data shows that its COVID-19 booster provides protection against omicron, but that a double dose of the booster shot provided a much greater increase in those levels. Its currently FDA-approved 50ug booster was found to increase neutralizing...
by Jordana Choucair | Dec 17, 2021 | Life Sciences
Regeneron Pharmaceuticals said its monoclonal antibody treatment for COVID-19 has “diminished potency” against the omicron variant but remains effective against delta. The drugmaker also said it is working on next-generation drugs that could protect...
by Jordana Choucair | Dec 17, 2021 | Life Sciences
The FDA said it will issue new guidance that will make abortion pills more accessible in some states, even after the pandemic. The move makes permanent pandemic-era guidance that allowed people to access the medication through telemedicine and receive the pills by...
Recent Comments